Global Oncology Molecular Diagnostics market cagr 10.3%

Page 1


Oncology Molecular Diagnostics Market

Oncology Molecular Diagnostics Market Scope:

Request Sample Report

Oncology Molecular Diagnostics Market Size and Growth

The Oncology Molecular Diagnostics market is experiencing robust growth, driven by increasing cancer incidences and technological advancements. The market size was valued at approximately $4 billion in 2022 and is projected to reach around $8 billion by 2030, reflecting a significant CAGR. Key trends include personalized medicine and targeted therapies.

Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Abbott Laboratories

◍ Bayer Healthcare

◍ Beckton Dickinson

◍ Cepheid

◍ Dako

◍ Danaher

◍ Gen Probe

◍ Qiagen

◍ Roche Diagnostics

◍ Siemens

◍ Sysmex

The Oncology Molecular Diagnostics Market features major players like Abbott Laboratories, Bayer Healthcare, and Roche Diagnostics, focusing on innovative testing solutions to enhance cancer detection and treatment monitoring. These companies drive market growth through advanced technologies, strategic collaborations, and extensive product portfolios, contributing to increased sales and improved patient outcomes. Sales Revenue (actual figures may vary):

- Abbott Laboratories: approximately $43 billion

- Roche Diagnostics: around $14 billion

- Danaher: about $29 billion

- Qiagen: near $2 billion

Request Sample Report

Market Segmentation

By Application

Infectious diseases

oncology ◍ Genetic tests ◍ Other

By Product

◍ PCR

INAAT ◍ DNA sequencing & NGS ◍ In situ hybridization

DNA microarrays

Other

Request Sample Report

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.